JP2021517134A5 - - Google Patents
Info
- Publication number
- JP2021517134A5 JP2021517134A5 JP2020547036A JP2020547036A JP2021517134A5 JP 2021517134 A5 JP2021517134 A5 JP 2021517134A5 JP 2020547036 A JP2020547036 A JP 2020547036A JP 2020547036 A JP2020547036 A JP 2020547036A JP 2021517134 A5 JP2021517134 A5 JP 2021517134A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- comprises administering
- method comprises
- treating
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862639650P | 2018-03-07 | 2018-03-07 | |
| US62/639,650 | 2018-03-07 | ||
| PCT/EP2019/055576 WO2019170750A1 (en) | 2018-03-07 | 2019-03-06 | Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021517134A JP2021517134A (ja) | 2021-07-15 |
| JP2021517134A5 true JP2021517134A5 (https=) | 2022-03-15 |
| JPWO2019170750A5 JPWO2019170750A5 (https=) | 2022-03-15 |
| JP7396991B2 JP7396991B2 (ja) | 2023-12-12 |
Family
ID=65894963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020547036A Active JP7396991B2 (ja) | 2018-03-07 | 2019-03-06 | 癌、潰瘍性大腸炎、及び関連する炎症性疾患の処置に有用な方法、並びにイソインドリン－１，３－ジオン及びイソインドールプロドラッグの組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11639332B2 (https=) |
| EP (1) | EP3762365B1 (https=) |
| JP (1) | JP7396991B2 (https=) |
| AR (1) | AR114666A1 (https=) |
| AU (1) | AU2019229583B2 (https=) |
| CA (1) | CA3093196A1 (https=) |
| ES (1) | ES2987705T3 (https=) |
| MA (1) | MA52266A (https=) |
| MX (1) | MX2020009288A (https=) |
| TW (1) | TW202000646A (https=) |
| WO (1) | WO2019170750A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118370746A (zh) * | 2024-04-25 | 2024-07-23 | 江苏省中医院 | 马尿酸在制备溃疡性结肠炎治疗药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2472965A (en) | 1949-06-14 | Metallized tetrakisazo dyes | ||
| US3951943A (en) | 1974-03-18 | 1976-04-20 | Chemetron Corporation | Coupling process in the preparation of disazo diimides |
| EP0856562A1 (en) | 1997-01-31 | 1998-08-05 | Hodogaya Chemical Co Ltd | Recording liquid and novel metal complex compound contained therein |
| US7182953B2 (en) | 1999-12-15 | 2007-02-27 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| JPWO2002001667A1 (ja) * | 2000-06-29 | 2004-01-08 | 日本化薬株式会社 | 色素増感光電変換素子 |
| US7842662B2 (en) * | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| AU2008270363A1 (en) * | 2007-06-29 | 2009-01-08 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| CA2718601A1 (en) | 2008-03-27 | 2009-10-01 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| WO2012083153A1 (en) * | 2010-12-16 | 2012-06-21 | Nektar Therapeutics | Oligomer-containing apremilast moiety compounds |
| MX347928B (es) | 2011-01-10 | 2017-05-19 | Celgene Corp | Derivados de fenetilsulfona isoindolina y su uso. |
-
2019
- 2019-03-06 WO PCT/EP2019/055576 patent/WO2019170750A1/en not_active Ceased
- 2019-03-06 JP JP2020547036A patent/JP7396991B2/ja active Active
- 2019-03-06 US US16/970,598 patent/US11639332B2/en active Active
- 2019-03-06 CA CA3093196A patent/CA3093196A1/en active Pending
- 2019-03-06 MX MX2020009288A patent/MX2020009288A/es unknown
- 2019-03-06 TW TW108107510A patent/TW202000646A/zh unknown
- 2019-03-06 ES ES19712695T patent/ES2987705T3/es active Active
- 2019-03-06 MA MA052266A patent/MA52266A/fr unknown
- 2019-03-06 AU AU2019229583A patent/AU2019229583B2/en active Active
- 2019-03-06 EP EP19712695.6A patent/EP3762365B1/en active Active
- 2019-03-06 AR ARP190100547A patent/AR114666A1/es unknown